As COVID-19 continues to spread at high rates, researchers have been looking at ways to repurpose drugs that the U.S. Food and Drug Administration has already approved of to fight the virus — including melatonin, a hormone that many use as an over-the-counter sleep aid.
The clinic reports that patients who used melatonin were 30 percent less likely to test positive for COVID-19 (with adjustments for race, age and health backgrounds). African Americans were 52 percent less likely to test positive, the clinic said.
“It is very important to note these findings do not suggest people should start to take melatonin without consulting their physician,” Feixiong Cheng, PhD, one of the study’s authors said in a statement. “Large-scale observational studies and randomized controlled trials are critical to validate the clinical benefit of melatonin for patients with COVID-19, but we are excited about the associations put forth in this study and the opportunity to further explore them.”
Read about the full report (and artificial intelligence platform used) published in PLOS Biology right here.
Get the latest headlines on FOX8.com below:
- Newsfeed Now: House to deliver articles of impeachment to Senate, Bucs make Super Bowl history
- Senators to introduce bill to raise Ohio minimum wage
- Merck ends development of 2 potential COVID-19 vaccines after poor results
- Lighter Eats Road Trip: 24 Karrot Kitchen
- January 25, 2021 Road Trip: Lighter Eats